pharmaceutical investing Tetraphase Pharmaceuticals Announces Adoption of Commission Decision Granting Marketing Authorisation Approval in the European Union for XERAVA
pharmaceutical investing Tetraphase Pharmaceuticals Receives Positive CHMP Opinion for Xerava as a Treatment for Complicated Intra-Abdominal Infections
pharmaceutical investing Tetraphase Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results
pharmaceutical investing Tetraphase Pharmaceuticals Announces FDA Acceptance for Filing of its NDA Submission for Eravacycline
pharmaceutical investing Tetraphase Pharmaceuticals Enters into Exclusive Development and Commercialization Agreement with Everest Medicines
pharmaceutical investing Tetraphase Announces Top-Line Results from IGNITE3 Phase 3 Clinical Trial of Eravacycline
QIMC Announces Thermogenic Wet-Gas Signature in 86% of Soil-Gas Samples at New Salem-Apple River, Nova Scotia, Next to Its 30% Clean Hydrogen Discovery
Standard Uranium Initiates Partner Funded Surface Exploration Program at the Corvo Uranium Project, Eastern Athabasca Basin, Saskatchewan
Brixton Metals Drills 4 m of 1,975 g/t Silver within 23.50 m of 348 g/t Silver in Hole 449 at its Langis Project in Ontario
